日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials

基于模型的COPD随机试验中汇总和个体FEV1数据的综合荟萃分析

Yang, Liang; Llanos-Paez, Carolina; Yang, Shuying; Ambery, Claire; Berges, Alienor; Kjellsson, Maria C; Karlsson, Mats O

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

达格列净治疗伴或不伴2型糖尿病的COVID-19住院患者的疗效和安全性:DARE-19随机试验的预设分析

Abdel Jawad, Mohammad; Furtado, Remo H M; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Langkilde, Anna Maria; Ambery, Philip; Patel, Shachi; Gosch, Kensey; Windsor, Sheryl L; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Javaheri, Ali; Saraiva, J F Kerr; Maia, Lilia Nigro; Berwanger, Otavio; Sauer, Andrew J; Kosiborod, Mikhail N

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease

在糖尿病和非糖尿病慢性肾脏病患者中,齐博坦坦联合达格列净治疗与单用达格列净治疗的效果比较

Wasehuus, Victor; Smeijer, J David; Ambery, Phil; Greasley, Peter J; Wijkmark, Emma; Wheeler, David C; Rossing, Peter; Heerspink, Hiddo J L

Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis.

慢性肝病原发性硬化性胆管炎中内皮素受体拮抗剂和钠-葡萄糖协同转运蛋白 2 抑制剂的治疗靶点定位。

Kuc Rhoda E, Paterson Anna L, Williams Thomas L, Gelson William T H, Greasley Peter J, Ambery Phil, Maguire Janet J, Davenport Anthony P

Disease Progression, Clinical Outcomes and Treatment Challenges in Patients with Chronic Kidney Disease and High-Risk Proteinuria

慢性肾脏病合并高危蛋白尿患者的疾病进展、临床结局和治疗挑战

Pecoits-Filho, Roberto; Bodegård, Johan; Ambery, Phil; Nam, You-Seon; Thuresson, Marcus; Svensson, Maria K

Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study

儿童患者抗凝药物处方趋势、出血事件和逆转剂使用情况:一项回顾性真实世界研究

D'Abrantes, Sofia; Male, Christoph; Brown, Nick; Bjursell, Mikael; Ambery, Philip; Berggren, Anders; Mattsson, Ulrika

Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum Disease

临床表型或许能够识别患有非酒精性脂肪肝谱系疾病的人群。

Geyer, Bridget M; Chang, Feier; Wu, Peng; Goldstein, Benjamin A; Wegermann, Kara; Chung, Sunny L; Phelan, Matthew; Wawrzynski, Joseph; Henson, Jacqueline B; Lee, Howard; Ambery, Phil; Moylan, Cynthia A; Pagidipati, Neha

Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD

Zibotentan 单药及与 Dapagliflozin 联合用药对 CKD 患者体液潴留的影响

Smeijer, J David; Wasehuus, Victor S; Dhaun, Neeraj; Górriz, José Luis; Soler, Maria José; Åstrand, Magnus; Mercier, Anne-Kristina; Greasley, Peter J; Ambery, Phil; Heerspink, Hiddo J L

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial

齐博坦坦和达格列净治疗慢性肾脏病患者的疗效和安全性:ZENITH-CKD试验的研究设计和基线特征

Heerspink, Hiddo J L; Greasley, Peter J; Ahlström, Christine; Althage, Magnus; Dwyer, Jamie P; Law, Gordon; Wijkmark, Emma; Lin, Min; Mercier, Anne-Kristina; Sunnåker, Mikael; Turton, Michelle; Wheeler, David C; Ambery, Philip

Co-localization of the sodium-glucose co-transporter-2 channel (SGLT-2) with endothelin ETA and ETB receptors in human cardiorenal tissue

钠-葡萄糖共转运体-2 通道 (SGLT-2) 与内皮素 ETA 和 ETB 受体在人类心肾组织中的共定位

Thomas L Williams, Rhoda E Kuc, Anna L Paterson, George R Abraham, Anna L Pullinger, Janet J Maguire, Sanjay Sinha, Peter J Greasley, Philip Ambery, Anthony P Davenport